Patient Engagement Study to Evaluate the Use of Biological Therapies for Cardiac Arrhythmias
NCT ID: NCT05032495
Last Updated: 2024-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
22 participants
OBSERVATIONAL
2022-05-01
2023-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia
NCT02919618
Early Ablation Therapy for the Treatment of Ischemic Ventricular Tachycardia in Patients With Implantable Cardioverter Defibrillators
NCT01557842
Proton Particle Therapy for Cardiac Arrhythmia
NCT04392193
Characterization of Cardiac Electrophysiological Effects of Autonomic Neuromodulation
NCT05377216
Electrocardiographic Mapping and Imaging
NCT01394965
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Heart patients who experienced a cardiac arrhythmia while in hospital,
2. Heart patients who did not experience a cardiac arrhythmia while in hospital,
3. Heart patients with an upcoming procedure that have not had a cardiac arrhythmia,
4. Members of the general public.
There will be a presentation, two surveys and a team meeting. Results will be compiled and analyzed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heart patients who experienced a cardiac arrhythmia while in hospital
Heart patients who experienced a cardiac arrhythmia while in hospital
Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
Focus group
To answer any questions and discuss topics covered in the standard presentation.
Heart patients who did not experience a cardiac arrhythmia while in hospital
Heart patients who did not experience a cardiac arrhythmia while in hospital
Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
Focus group
To answer any questions and discuss topics covered in the standard presentation.
Heart patients with an upcoming procedure that have not had a cardiac arrhythmia
Heart patients with an upcoming procedure that have not had a cardiac arrhythmia
Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
Focus group
To answer any questions and discuss topics covered in the standard presentation.
Members of the general public
Members of the general public
Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
Focus group
To answer any questions and discuss topics covered in the standard presentation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Surveys
Surveys to evaluate prior experience, opinions and intervention acceptability.
Focus group
To answer any questions and discuss topics covered in the standard presentation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ottawa Heart Institute Research Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Darryl Davis
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Darryl Davis
Role: PRINCIPAL_INVESTIGATOR
Ottawa Heart Institute Research Corporation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Ottawa Heart Insitute
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Smith C, Lalu MM, Davis DR. Exploring Patient Viewpoints to Optimize Implementation of a Biological Therapy for Atrial Fibrillation Prevention. CJC Open. 2024 Apr 16;6(7):893-900. doi: 10.1016/j.cjco.2024.04.003. eCollection 2024 Jul.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.